{"id":33028,"date":"2017-12-20T10:35:12","date_gmt":"2017-12-20T18:35:12","guid":{"rendered":"https:\/\/cjnotebook.com\/?p=33028"},"modified":"2017-12-20T10:35:12","modified_gmt":"2017-12-20T18:35:12","slug":"33028-2","status":"publish","type":"post","link":"https:\/\/cjnotebook.com\/?p=33028","title":{"rendered":"Drug Maker Agrees to Pay $210 Million for  Paying Kickbacks"},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\"><strong>MARYLAND<\/strong><\/span><\/p>\n<hr \/>\n<div class=\"field field--name-field-pr-body field--type-text-long field--label-hidden\">\n<div class=\"field__items\">\n<div class=\"field__item even\">\n<figure id=\"attachment_3810\" aria-describedby=\"caption-attachment-3810\" style=\"width: 300px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3810\" src=\"https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/06\/Government-Accountability-Office-Report-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/06\/Government-Accountability-Office-Report-300x200.jpg 300w, https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/06\/Government-Accountability-Office-Report-90x60.jpg 90w, https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/06\/Government-Accountability-Office-Report-180x120.jpg 180w, https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/06\/Government-Accountability-Office-Report-95x64.jpg 95w, https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/06\/Government-Accountability-Office-Report.jpg 408w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><figcaption id=\"caption-attachment-3810\" class=\"wp-caption-text\">Source: Government Accountability Report<\/figcaption><\/figure>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics&#8217;s pulmonary arterial hypertension drugs, officials announced Wednesday.<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">This practice is in violation of federal law, official said.<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">When a Medicare beneficiary obtains a prescription drug covered by Medicare Part B or Part D, the beneficiary may be required to make a partial payment, which may take the form of a copayment, coinsurance, or deductible (collectively \u201ccopays\u201d), according to authorities.<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">These copay obligations may be substantial for expensive medications.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">Congress included copay requirements in these programs, in part, to encourage market forces to serve as a check on health care costs\u2014including the prices that pharmaceutical manufacturers can demand for their drugs.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">Under the Anti-Kickback Statute, a pharmaceutical company is prohibited from offering or paying, directly or indirectly, any remuneration\u2014which includes money or any other thing of value\u2014 to induce Medicare patients to purchase the company\u2019s product.\u00a0 \u00a0\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">Therapeutics Corporation\u00a0\u00a0sells a number of pulmonary arterial hypertension drugs, including Adcirca, Remodulin, Tyvaso, and Orenitram (the \u201cSubject Dugs\u201d).\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">The government alleged that United Therapeutics used a foundation, which claims 501(c)(3) status for tax purposes, as a conduit to pay the copay obligations of thousands of Medicare patients taking the Subject Drugs.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">In particular, from 2010 to 2014, United Therapeutics allegedly made donations to the foundation, which, in turn, used those donations to pay copays for the Subject Drugs to induce patients to purchase these drugs.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">The government alleged that United Therapeutics routinely obtained data from the foundation detailing how much the foundation had spent for patients on each Subject Drug and that this data was used by United Therapeutics to decide how much to donate to the foundation.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">The Government also alleged that United Therapeutics had a policy of not permitting needy Medicare patients to participate in its free drug program, which was open to other financially needy patients, and instead referred Medicare patients to the foundation, which allowed claims to be submitted to Medicare.<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">\u201cWhile we support efforts to provide patients with access to needed medications, such assistance must comply with federal law.\u00a0 Today\u2019s settlement shows that the government will hold accountable drug companies that attempt to use illegal kickbacks to defeat mechanisms Congress designed to act as a check on drug pricing and healthcare costs,\u201d said Acting Assistant Attorney General Chad A. Readler of the Justice Department\u2019s Civil Division.\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">\u00a0United Therapeutics has also entered into a corporate integrity agreement (CIA) with the Department of Health and Human Services Office of Inspector General.\u00a0 <\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">The five-year CIA requires, among other things, that UT implement measures designed to ensure that arrangements and interactions with third-party patient assistance programs are compliant with the law.\u00a0 <\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">In addition, the CIA requires reviews by an independent review organization, compliance-related certifications from company executives and Board members, and the implementation of a risk assessment and mitigation process.<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">\u201cOur corporate integrity agreement requires United Therapeutics to implement controls and monitoring designed to promote true independence from any patient assistance programs to which it donates,\u201d said Gregory E. Demske, Chief Counsel to the Inspector General for the U.S. Department of Health and Human Services.\u00a0 \u201cWithout true independence, a drug company can use a foundation as a conduit for improper payments that expose the taxpayer-funded Medicare program to the risk of abuse.\u201d\u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">\u201cUT\u00a0 (United Therapeutics) used a third party to do exactly what it knew it could not lawfully do itself,\u201d said Acting United States Attorney William D. Weinreb.\u00a0 \u201cAccording to the allegations in today\u2019s settlement agreement, UT understood that the third-party foundation used UT\u2019s money to cover the co-pays of patients taking UT drugs.\u00a0 UT\u2019s payments to the foundation were not charity for PAH patients generally, but rather were a way to funnel money to patients taking UT drugs.\u00a0 The Anti-Kickback Statute exists to protect Medicare, and the taxpayers who fund it, from schemes like these that leave Medicare holding the bag for the costs of expensive drugs.\u201d<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-size: 14pt;\">\u00a0<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MARYLAND Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,3],"tags":[179],"class_list":["post-33028","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-main-slider","category-u-s-department-of-justice","tag-medicare"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drug Maker Agrees to Pay $210 Million for Paying Kickbacks<\/title>\n<meta name=\"description\" content=\"Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics&#039;s pulmonary arterial hypertension drugs, officials announced Wednesday.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cjnotebook.com\/?p=33028\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks\" \/>\n<meta property=\"og:description\" content=\"Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics&#039;s pulmonary arterial hypertension drugs, officials announced Wednesday.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cjnotebook.com\/?p=33028\" \/>\n<meta property=\"og:site_name\" content=\"American Justice Notebook\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmericanJusticeNotebook\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-20T18:35:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cjnotebook.com\/wp-content\/uploads\/2017\/12\/United-Therapeutics-.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"416\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Raul\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Raul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028\"},\"author\":{\"name\":\"Raul\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#\\\/schema\\\/person\\\/f5521baddca77b521f012298775186c0\"},\"headline\":\"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks\",\"datePublished\":\"2017-12-20T18:35:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028\"},\"wordCount\":700,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cjnotebook.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/United-Therapeutics-.jpg\",\"keywords\":[\"Medicare\"],\"articleSection\":[\"Home Main Slider\",\"U.S. Department of Justice\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cjnotebook.com\\\/?p=33028#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028\",\"url\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028\",\"name\":\"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cjnotebook.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/United-Therapeutics-.jpg\",\"datePublished\":\"2017-12-20T18:35:12+00:00\",\"description\":\"Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics's pulmonary arterial hypertension drugs, officials announced Wednesday.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cjnotebook.com\\\/?p=33028\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/?p=33028#primaryimage\",\"url\":\"https:\\\/\\\/cjnotebook.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/United-Therapeutics-.jpg\",\"contentUrl\":\"https:\\\/\\\/cjnotebook.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/United-Therapeutics-.jpg\",\"width\":416,\"height\":416},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#website\",\"url\":\"https:\\\/\\\/cjnotebook.com\\\/\",\"name\":\"American Justice Notebook\",\"description\":\"&quot;Our liberty depends on the freedom of the press, and that cannot be limited without being lost.&quot; \u2014  Thomas Jefferson\",\"publisher\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cjnotebook.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#organization\",\"name\":\"American Justice Notebook\",\"url\":\"https:\\\/\\\/cjnotebook.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cjnotebook.com\\\/wp-content\\\/uploads\\\/2014\\\/07\\\/Justice-Scales.jpg\",\"contentUrl\":\"https:\\\/\\\/cjnotebook.com\\\/wp-content\\\/uploads\\\/2014\\\/07\\\/Justice-Scales.jpg\",\"width\":675,\"height\":231,\"caption\":\"American Justice Notebook\"},\"image\":{\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmericanJusticeNotebook\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cjnotebook.com\\\/#\\\/schema\\\/person\\\/f5521baddca77b521f012298775186c0\",\"name\":\"Raul\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c7f80bd073aca2abc2fc18e390e13d00b72d9d3a81bca4fd53e3567b02efee6f?s=96&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c7f80bd073aca2abc2fc18e390e13d00b72d9d3a81bca4fd53e3567b02efee6f?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c7f80bd073aca2abc2fc18e390e13d00b72d9d3a81bca4fd53e3567b02efee6f?s=96&r=g\",\"caption\":\"Raul\"},\"description\":\"Raul Hernandez is a former journalist. He has worked as a newspaper reporter for more than 30 years at the El Paso Herald-Post, El Paso Times, Press Enterprise in Riverside, California and the Ventura County Star in California. He was a court reporter for more than 20 years.\",\"sameAs\":[\"https:\\\/\\\/cjnotebook.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks","description":"Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics's pulmonary arterial hypertension drugs, officials announced Wednesday.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cjnotebook.com\/?p=33028","og_locale":"en_US","og_type":"article","og_title":"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks","og_description":"Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics's pulmonary arterial hypertension drugs, officials announced Wednesday.","og_url":"https:\/\/cjnotebook.com\/?p=33028","og_site_name":"American Justice Notebook","article_publisher":"https:\/\/www.facebook.com\/AmericanJusticeNotebook","article_published_time":"2017-12-20T18:35:12+00:00","og_image":[{"width":416,"height":416,"url":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2017\/12\/United-Therapeutics-.jpg","type":"image\/jpeg"}],"author":"Raul","twitter_misc":{"Written by":"Raul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cjnotebook.com\/?p=33028#article","isPartOf":{"@id":"https:\/\/cjnotebook.com\/?p=33028"},"author":{"name":"Raul","@id":"https:\/\/cjnotebook.com\/#\/schema\/person\/f5521baddca77b521f012298775186c0"},"headline":"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks","datePublished":"2017-12-20T18:35:12+00:00","mainEntityOfPage":{"@id":"https:\/\/cjnotebook.com\/?p=33028"},"wordCount":700,"commentCount":0,"publisher":{"@id":"https:\/\/cjnotebook.com\/#organization"},"image":{"@id":"https:\/\/cjnotebook.com\/?p=33028#primaryimage"},"thumbnailUrl":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2017\/12\/United-Therapeutics-.jpg","keywords":["Medicare"],"articleSection":["Home Main Slider","U.S. Department of Justice"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cjnotebook.com\/?p=33028#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cjnotebook.com\/?p=33028","url":"https:\/\/cjnotebook.com\/?p=33028","name":"Drug Maker Agrees to Pay $210 Million for Paying Kickbacks","isPartOf":{"@id":"https:\/\/cjnotebook.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cjnotebook.com\/?p=33028#primaryimage"},"image":{"@id":"https:\/\/cjnotebook.com\/?p=33028#primaryimage"},"thumbnailUrl":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2017\/12\/United-Therapeutics-.jpg","datePublished":"2017-12-20T18:35:12+00:00","description":"Pharmaceutical company United Therapeutics Corporation, based in Silver Spring, Maryland, agreed to pay $210 million to resolve claims that it used a foundation as a conduit to pay the copays of Medicare patients taking United Therapeutics's pulmonary arterial hypertension drugs, officials announced Wednesday.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cjnotebook.com\/?p=33028"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cjnotebook.com\/?p=33028#primaryimage","url":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2017\/12\/United-Therapeutics-.jpg","contentUrl":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2017\/12\/United-Therapeutics-.jpg","width":416,"height":416},{"@type":"WebSite","@id":"https:\/\/cjnotebook.com\/#website","url":"https:\/\/cjnotebook.com\/","name":"American Justice Notebook","description":"&quot;Our liberty depends on the freedom of the press, and that cannot be limited without being lost.&quot; \u2014  Thomas Jefferson","publisher":{"@id":"https:\/\/cjnotebook.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cjnotebook.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cjnotebook.com\/#organization","name":"American Justice Notebook","url":"https:\/\/cjnotebook.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cjnotebook.com\/#\/schema\/logo\/image\/","url":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/07\/Justice-Scales.jpg","contentUrl":"https:\/\/cjnotebook.com\/wp-content\/uploads\/2014\/07\/Justice-Scales.jpg","width":675,"height":231,"caption":"American Justice Notebook"},"image":{"@id":"https:\/\/cjnotebook.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmericanJusticeNotebook"]},{"@type":"Person","@id":"https:\/\/cjnotebook.com\/#\/schema\/person\/f5521baddca77b521f012298775186c0","name":"Raul","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c7f80bd073aca2abc2fc18e390e13d00b72d9d3a81bca4fd53e3567b02efee6f?s=96&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c7f80bd073aca2abc2fc18e390e13d00b72d9d3a81bca4fd53e3567b02efee6f?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c7f80bd073aca2abc2fc18e390e13d00b72d9d3a81bca4fd53e3567b02efee6f?s=96&r=g","caption":"Raul"},"description":"Raul Hernandez is a former journalist. He has worked as a newspaper reporter for more than 30 years at the El Paso Herald-Post, El Paso Times, Press Enterprise in Riverside, California and the Ventura County Star in California. He was a court reporter for more than 20 years.","sameAs":["https:\/\/cjnotebook.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/posts\/33028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33028"}],"version-history":[{"count":1,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/posts\/33028\/revisions"}],"predecessor-version":[{"id":33030,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/posts\/33028\/revisions\/33030"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=\/wp\/v2\/media\/33029"}],"wp:attachment":[{"href":"https:\/\/cjnotebook.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cjnotebook.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}